JPRN-UMIN000007001已完成未知
Alternating Chemotherapy and Radiotherapy in Advanced Laryngeal Cancers - Alternating Chemotherapy and Radiotherapy in Advanced Laryngeal Cancers
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 26
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Previously treated patients 2)A history of radiation therapy 3)Serious complication 4)A history of cerebral infarction
研究者
相似试验
已完成
不适用
Study of alternating chemoradiotherapy combined with proton beam therapy and intra-arterial infusion chemotherapy for advanced tongue cancerlocally advenced tongue cancerJPRN-UMIN000032732Department of radiation oncology, Southern Tohoku Proton Therapy Center30
尚未招募
2 期
Combination of chemoTherapy aNd chemoradioTherapy for adenocarcinoma of the OESophagus and gastro-oesophageal junction with limited metastatic disease - TNT-OES-1 TRIAesophageal cancerNL-OMON49762Erasmus MC, Universitair Medisch Centrum Rotterdam20
招募中
不适用
Combination of chemoTherapy aNd chemoradioTherapy for adenocarcinoma of the OESophagus and gastro-oesophageal junction with oligometastatic diseaseNL-OMON23939Erasmus MC20
进行中（未招募）
1 期
Chemotherapy followed by chemoradiotherapy for metastatic esophageal cancerPatients (18 – 75 years) who are diagnosed with adenocarcinoma of the oesophagus or GOJ with a resectable primary tumour and de-novo synchronous oligometastatic disease.EUCTR2020-003605-55-NLErasmus MC - University Medical Centre20
进行中（未招募）
不适用
ow-doses radiotherapy and concomitant chemotherapy with pemetrexed in progression desease NSCLC: a dose-descalation phase II study - NDadvanced and/or metastatic NSCLCMedDRA version: 9.1Level: LLTClassification code 10059515Term: Non-small cell lung cancer metastaticEUCTR2008-003690-40-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI